An Open-label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK3326595 in Participants With Solid Tumors and Non-Hodgkin's Lymphoma
Clinical trial NCT02783300 · COMPLETED
Trial details
- NCT number
- NCT02783300
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-30
- Primary completion
- 2023-08-30
- Enrollment
- 297
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.